Designing of multi-epitope based vaccine against SARS COV-2, using reverse vaccinology approach

Authors

  • Rik Ganguly Department of Biotechnology and Bioinformatics, North-Eastern Hill University, Shillong 793022, Meghalaya, India
  • Angneh Ngoruh Department of Biotechnology and Bioinformatics, North-Eastern Hill University, Shillong 793022, Meghalaya, India
  • Prosperwell Ingty Department of Biotechnology and Bioinformatics, North-Eastern Hill University, Shillong 793022, Meghalaya, India
  • Atanu Bhattacharjee Department of Biotechnology and Bioinformatics, North-Eastern Hill University, Shillong 793022, Meghalaya, India

Abstract

SARS Coronavirus-2 (SARS-CoV-2) pandemic has shown a devastating effect worldwide. More than 1.62 million people have lost their life due to this dangerous virus and it has become one of the major concerns worldwide. It has become an emerging global issue concerning different scientific communities. Here an attempt has been made to develop a vaccine against the SARS-CoV-2 virus using epitope-based subunit vaccines and reverse vaccinology and immunoinformatics methods. With the help of computational experimentations and multi-epitope-based drug designing studies, we have successfully designed 5 different vaccine structures which were further analyzed for insilco toxicity as well as molecular interaction studies.  Significant interacting candidates were further subjected to insilco immuno simulation for the data point of about a year time. This work could provide new hope for development of effective vaccine in the face of global threat arising from the emerging virus.

Keywords:

epitope, vaccinology, ImmunoInformatics, SARS-CoV-2

DOI

https://doi.org/10.25004/IJPSDR.2022.140415

References

Hopkins DR. The greatest killer: smallpox in history. University of Chicago Press, 2002.

Boylston A. The origins of inoculation. J R Soc Med. 2012; 105:309-313.

Weniger BG, Papania MJ. Alternative vaccine delivery methods. Vaccines 2013; 1200-1231.

Leung AKC. “Variolation” and Vaccination in Late Imperial China, Ca 1570-1911. History of Vaccine Development, Edn 5, Vol. 2, Springer, New York, 2011, pp. 5-12.

Riedel S. Edward Jenner and the history of smallpox and vaccination. Proc (Bayl Univ Med Cent). 2005; 18:21-25.

Weiss RA, Esparza J. The prevention and eradication of smallpox: a commentary on Sloane (1755) 'An account of inoculation'. Philos Trans R Soc Lond B Biol Sci. 2015; 370:20140378.

John TJ, Samuel R. Herd immunity and herd effect: new insights and definitions. Eur J Epidemiol. 2000; 16:601-606.

Sahai A, Ahamad SS. A survey on the use of the disposable bioreactor for growth of adherent cell lines for manufacturing of viral vaccine. IJARET. 2020; 11:898-910.

Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol. 2021; 21:83-100.

O'Hagan DT, MacKichan ML, Singh M. Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng. 2001; 18:69-85.

Morelli L, Poletti L, Lay L. Carbohydrates and immunology: synthetic oligosaccharide antigens for vaccine formulation. Eur. J. Org. Chem. 2011; 2011:5723-5777.

Ellis GK, Bone HG, Chlebowski R, et al. Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J Clin Oncol. 2008; 26:4875-4882.

Leroux-Roels G. Vaccine Unmet needs in modern vaccinology: adjuvants to improve the immune response. Vaccine. 2010; 28 Suppl 3:C25-C36.

Clem AS. Fundamentals of vaccine immunology. J Glob Infect Dis. 2011; 3:73-78.

Ribas A, Butterfield LH, Glaspy JA, Economou JS. Current developments in cancer vaccines and cellular immunotherapy. J Clin Oncol. 2003; 21:2415-2432.

Ponomarenko JV, Van RMH. B cell epitope prediction. Edn 2, Vol. 2, Structural bioinformatics, Wiley-Blackwell, 2009, pp. 849-879.

Cohn M. Degeneracy, mimicry and crossreactivity in immune recognition. Mol Immunol. 2005; 42:651-655.

Draheim M, Wlodarczyk MF, Crozat K, et al. Profiling MHC II immunopeptidome of blood-stage malaria reveals that cDC1 control the functionality of parasite-specific CD4 T cells. EMBO Mol Med. 2017; 9:1605-1621.

Black M, Trent A, Tirrell M, Olive C. Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists. Expert Rev Vaccines. 2010; 9:157-173.

Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev. 2005; 206:32-63.

Zuniga EI, McGavern DB, Oldstone MBA. Antigen Presentation. Vol. 3, Encyclopedia of Virology, Academic press, 2008, pp. 21-126.

Nicholson LB. The immune system. Essays Biochem. 2016; 60:275-301.

Janeway CA Jr, Travers P, Walport M. Immunological memory: Immunobiology: The Immune System in Health and Disease. New York: Garland Science, 2001.

Sautto GA, Kirchenbaum GA, Ross TM. Towards a universal influenza vaccine: different approaches for one goal. Virol J. 2018; 15:17.

Sarkar B, Ullah MA, Johora FT, Taniya MA, Araf Y. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2). Immunobiology. 2020; 225:151955.

Ismail S, Ahmad S, Azam SS. Vaccinomics to design a novel single chimeric subunit vaccine for broad-spectrum immunological applications targeting nosocomial Enterobacteriaceae pathogens. Eur. J. Pharm. Sci. 2020; 146:105258.

Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC bioinform. 2007; 8,1-7.

Dimitrov I, Bangov I, Flower DR. AllerTOP v.2-a server for in silico prediction of allergens. J. Mol. Model. 2007; 20:2278.

Shin WH, Lee GR, Heo L, Lee H, Seok C. Prediction of protein structure and interaction by GALAXY protein modeling programs. Bio Design. 2014; 2, 1-11.

Laskowski RA, MacArthur MW, Moss DS. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993; 26:283-291.

Yumeng Y, Di Z, Pei Z. HDOCK: a web server for protein–protein and protein–DNA/RNA docking based on a hybrid strategy. Nucleic Acids Res. 2017; 45: W365-W373.

Abhishek S, Mukesh T, Lalit KS. Designing a multi-epitope peptide-based vaccine against SARS-CoV-2. Sci. Rep. 2020; 10:16219.

Filippo C, Massimo B. C-ImmSim∗: playing with the immune response. Sixteenth International Symposium on Mathematical Theory of Networks and Systems (MTNS2004). In the proceedings of the 2004 Sixteenth International Symposium on Mathematical Theory of Networks and Systems, 2004, pp. 1-7.

Published

30-07-2022
Statistics
Abstract Display: 766
PDF Downloads: 410
Dimension Badge

How to Cite

“Designing of Multi-Epitope Based Vaccine Against SARS COV-2, Using Reverse Vaccinology Approach”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 14, no. 4, July 2022, pp. 485-92, https://doi.org/10.25004/IJPSDR.2022.140415.

Issue

Section

Research Article

How to Cite

“Designing of Multi-Epitope Based Vaccine Against SARS COV-2, Using Reverse Vaccinology Approach”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 14, no. 4, July 2022, pp. 485-92, https://doi.org/10.25004/IJPSDR.2022.140415.